Lin CM, Chen JC, Meyerowitz-Katz G, Huang YN, et al. Unexpected cardiovascular risks of glucagon-like peptide-1 receptor agonist and aspirin co-administration in individuals with obesity, with and without type 2 diabetes: A propensity score matched cohort study. Diabetes Obes Metab 2025 Jan 13. doi: 10.1111/dom.16191.
PMID: 39806559